Targeting replication stress in triple negative breast cancer treatment regimen: An emerging approach

被引：0
|
作者：
Rajamanickam, Subapriya
Park, Jun Hyoung
Bates, Kaitlyn
Timilsina, Santosh
Eedunuri, Vijay Kumar
Onyeagucha, Benjamin
Subbarayalu, Panneerdoss
Abdelfattah, Nourhan
Jung, Kwang Hwa
Favours, Edward
Mohammad, Tabrez A.
Chen, Hung-I Harry
Vadlamudi, Ratna K.
Chen, Yidong
Kaipparettu, Benny A.
Arbiser, Jack L.
Rao, Manjeet K.
机构：
[1] UT Hlth San Antonio, San Antonio, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Emory Univ, Sch Med, Atlanta, GA, Ukraine
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-06-04
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
    Green-Tripp, Gabriela
    Nattress, Callum
    Hallden, Gunnel
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [22] Therapeutic targeting of ERβ in triple negative breast cancer
    Reese, Jordan M.
    Subramaniam, Malayannan
    Suman, Vera J.
    Wu, Xianglin
    Negron, Vivian
    Gingery, Anne
    Pitel, Kevin S.
    Shah, Sejal S.
    Cunliffe, Heather E.
    McCullough, Ann E.
    Pockaj, Barbara A.
    Spelsberg, Thomas C.
    Goetz, Matthew P.
    Ingle, James N.
    Hawse, John R.
    CANCER RESEARCH, 2015, 75
  • [23] Dual targeting of Notch and Wnt/β-catenin pathways: Potential approach in triple-negative breast cancer treatment
    Fatma Nasser
    Nermine Moussa
    Maged W. Helmy
    Medhat Haroun
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 481 - 490
  • [24] Dual targeting of Notch and Wnt/β-catenin pathways: Potential approach in triple-negative breast cancer treatment
    Nasser, Fatma
    Moussa, Nermine
    Helmy, Maged W.
    Haroun, Medhat
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (03) : 481 - 490
  • [25] Triple-negative breast cancer: advancements in characterization and treatment approach
    Hurvitz, Sara
    Mead, Monica
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2016, 28 (01) : 59 - 69
  • [26] A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer
    Del Bano, Joanie
    Flores-Flores, Remy
    Josselin, Emmanuelle
    Goubard, Armelle
    Ganier, Laetitia
    Castellano, Remy
    Chames, Patrick
    Baty, Daniel
    Kerfelec, Brigitte
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [27] A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathway
    Pardo, Isabele
    Fagundes, Pedro Brecheret
    de Oliveira, Rafael Santana
    Campregher, Paulo Vidal
    EINSTEIN-SAO PAULO, 2024, 22 : 1 - 6
  • [28] Targeting the glycolytic pathway as an effective therapeutic approach for triple-negative breast cancer
    Pelicano, Helene
    Zhang, Wan
    Hammoudi, Naima
    Pusztai, Lajos
    Dai, Jiale
    Huang, Peng
    CANCER RESEARCH, 2010, 70
  • [29] Advancements in clinical research and emerging therapies for triple-negative breast cancer treatment
    Xu, Lili
    Xu, Pengtao
    Wang, Jingsong
    Ji, Hui
    Zhang, Lin
    Tang, Zhihua
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 988
  • [30] Triple-Negative Breast Cancer: Emerging Biomarkers for Early Diagnosis, Prognosis, and Treatment
    Roshanizadeh, Zahra
    Haghshenas, Mohammad Reza
    Ghaderi, Abbas
    MIDDLE EAST JOURNAL OF CANCER, 2024, 15 (04) : 257 - 271
12345